INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-2210195887-tablet-phone-recruitment]( "How To Reduce Eligibility Risk And Prevent Protocol Deviations")
How To Reduce Eligibility Risk And Prevent Protocol DeviationsEliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
![GettyImages-1282633951-laptop-man-suit-office-quality-management]( "Endpoint Clinical RTSM: Getting The Job Done")
Endpoint Clinical RTSM: Getting The Job DoneExplore how a Job-to-be-Done (JTBD)-focused RTSM approach reduces delays, optimizes costs, and accelerates trial success through predictive intelligence and streamlined global workflows.
-
![yes your study is at risk]( "Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints")
Yes, Your Study Is At Risk: Risk Mitigation Plans For EndpointsOcular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
-
![Senior medical checkup patient and doctor-GettyImages-1938542779]( "Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials")
Navigating The 7 Biggest Challenges In Rare Disease Clinical TrialsDiscover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure1/14/2026
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
-
How Smarter Financial Strategies Improve Trial Performance3/10/2025
CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
-
The Pharmacy Advantage In Direct-To-Patient Clinical Supply3/24/2026
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
-
Automating The Clinical Trial Lifecycle With AI | TrialKit5/28/2026
AI-driven clinical trials replace manual steps with end-to-end automation, accelerating study setup, cutting costs, and delivering early insights through integrated simulation and analysis.
-
Human Abuse Potential: Study Management5/1/2026
Learn how human abuse potential studies are strengthened through thoughtful, targeted volunteer selection, clearly defined inclusion and exclusion criteria, and disciplined study oversight.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2161842577-business-professional-laptop-office-table]( "Overcome Biosafety Challenges With An Innovative IBC")
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![patient-engagement-GettyImages-1758104980]( "Patient Engagement And Retention For Clinical Trials")
Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.
With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.
-
![Big genomic data visualization-GettyImages-1367979256]( "Biostatistics: End-To-End Management")
Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
